ADARx Pharmaceuticals (ADRX) vs Stoke Therapeutics (STOK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ADARx Pharmaceuticals is the larger company by market cap ($1.89 billion vs $1.55 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | STOK |
|---|---|---|
| Share price | $17.68 | $23.95 |
| Market cap | $1.89B | $1.55B |
| 1-day change | +1.99% | -1.40% |
| YTD return | — | -24.54% |
| 1-year return | — | -21.48% |
| 5-year return | — | +1.83% |
| EPS (TTM) | $-1.16 | $-3.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $184.42M |
| Revenue growth (YoY) | — | +404.50% |
| Net income (latest FY) | — | $-6.88M |
| Operating margin | — | -11.16% |
| Net margin | — | -3.73% |
| 52-week high | $23.21 | $40.22 |
| 52-week low | $16.64 | $20.32 |
| Distance from 52-week high | -23.85% | -40.45% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +93.99% |
| Average volume | 1.25M | 855.13K |
| Shares outstanding | 106.80M | 64.53M |
| Employees | 100 | 170 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Stoke Therapeutics
STOK stock →Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression.
Health Care · Biotechnology: Pharmaceutical Preparations · 170 employees
ADRX vs STOK FAQ
Which is bigger, ADARx Pharmaceuticals or Stoke Therapeutics?
ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.89B compared with $1.55B for Stoke Therapeutics (STOK).
Are ADARx Pharmaceuticals and Stoke Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.